Home › Pancreatic Cancer › Illinois
Pancreatic Cancer clinical trials in Illinois
31 studies for Pancreatic Cancer are looking for participants at sites in Illinois.
Cities in Illinois
- Chicago20 studies
- Peoria7 studies
- Cicero6 studies
- Decatur6 studies
- Naperville6 studies
- Evanston6 studies
- Champaign5 studies
- Bloomington5 studies
- Springfield5 studies
- Aurora4 studies
- Galesburg4 studies
- Waukegan4 studies
- North Peoria4 studies
- Danville4 studies
- Elgin3 studies
- Charleston3 studies
- Arlington Heights3 studies
- Carbondale3 studies
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
- Northwestern Medicine Chicago Proton Center, Warrenville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT02598349Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- University of Chicago Medical Center, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621718A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413Pancreatic Cancer Detection Consortium
- OSF HealthCare, Peoria
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06388967A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Cancer Care Specialists of Illinois, Decatur
- Decatur Memorial Hospital, Decatur
- Hope and Healing Clinical Research LLC, Hinsdale
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437DESTINY-PANTUMOUR04
- Research Site, Decatur
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Illinois Cancer Specialists, Arlington Heights
- City of Hope, Chicago
- OSF Medical Center, Peoria
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07562152A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US079, Chicago
- Investigative Site US030, Evanston
- Investigative Site US005, Naperville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07522073Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
- OSF Saint Francis Medical Center, Peoria
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06271291CREO - Microwave Ablation Feasibility Study
- Rush University Medical Center, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07817147Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Carle BroMenn Outpatient Center, Bloomington
- and 52 more
RecruitingObservational study
Ages 50 to 75 · All sexes · Updated Sep 4, 2026 · NCT04239573A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06465069Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Northwestern University, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05372614Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Memorial Hospital East, Shiloh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT05687123Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- and 45 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06958328BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- Northwestern University, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07594626Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
RecruitingPhase 1/2
Ages 18 to 130 · All sexes · Updated Aug 12, 2026 · NCT05417594Pancreatic Cancer Early Detection Consortium
- Illinois CancerCare, Bloomington
- University of Chicago Medicine, Chicago
- NorthShore University HealthSystem, Evanston
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Jul 22, 2026 · NCT04970056Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
- Hope and Healing Cancer Services, Hinsdale
- Orchard Healthcare Research, Skokie
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06937177Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT05005403Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb
- Northwestern Medicine Cancer Center Delnor, Geneva
- Northwestern Medicine Cancer Center Warrenville, Warrenville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT04616131Lidocaine Infusion in Pancreatic Cancer
- University of Illnois at Chicago, Chicago
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT04048278Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- Memorial Hospital of Carbondale, Carbondale
- and 29 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06998940Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
- Northwestern University, Chicago
- University of Illinois, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 31, 2026 · NCT06807437A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Champaign
- Ohio State University-Telemedicine, Chicago
- Ohio State University Telemedicine, Quincy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- OSF Saint Anthony's Health Center, Alton
- Advocate Good Shepherd Hospital, Barrington
- Illinois CancerCare-Bloomington, Bloomington
- and 40 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
- Advocate Christ Medical Center, Oak Lawn
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 17, 2025 · NCT02843945CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Northwestern University, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 10, 2023 · NCT05733000From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.